How Should Life Sciences Organizations Modernize Their Compliance And Quality Management?

In QMS, rigid data silos are quickly giving way to a more holistic way of managing information and processes. More and more, organizations see the value in unlimited visibility of the business and its product lifecycles from ideation to commercialization.
While information silos are still relatively common, for example, in the quality supply chain R&D of life sciences organizations, the trend is for needless and unproductive barriers to be swept away as companies adopt comprehensive, connected business management systems.
Quality management systems (QMS) are enveloped by this drive to unfettered data flows, and therefore, can leverage the increased agility that becomes possible with them. For some older and larger organizations, that may mean reimagining the value of QMS. In their conversation, Huber and Shankar describe an approach that strikes healthy balance between compliance, quality, and transparency, embedded within an organization’s culture of ‘quality’.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.